AUB
SAGE

Atlantic Union Bankshares’s Sage Therapeutics SAGE Stock Holding History

Atlantic Union Bankshares’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$912 – 1688
2025
Q2 		$912 Buy
+100
New +$736 ﹤0.01% 1124

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Atlantic Union Bankshares's SAGE Position: Q3 2025 in Review

Atlantic Union Bankshares sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 100 shares — an estimated $912 sold.

Atlantic Union Bankshares first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $912 in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Atlantic Union Bankshares reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Atlantic Union Bankshares sold 100 Sage Therapeutics shares in Q3 2025, an estimated $912.
  • Atlantic Union Bankshares first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Atlantic Union Bankshares's Sage Therapeutics position peaked at $912 in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Atlantic Union Bankshares's 13F filing for Q3 2025, filed 4 Nov 2025.